The deal will see Imperative’s owner, Hastings Equity Partners, join with RSI’s owner One Equity Partners to recapitalize Imperative and simultaneously merge the two companies. Hastings initially invested in Imperative in 2014 and said it had boosted revenues at the oilfield chemicals company more than tenfold through both acquisitions and organic growth.
Imperative’s chief operating officer Ryan Havens will become CEO of the combined company, while RSI’s chief operating officer Garrett Tucker will continue in his role. “This deal is about driving new growth, improving asset leverage, increasing strategic flexibility, and achieving non-labor synergies,” Havens said.
RSI’s CEO Curtis Bordelon will retire and Imperative’s CEO, Neil Harrop will serve on the merged group’s board of directors.
Headquartered in Midland, Texas, Imperative provides production and completion chemical, acid stimulation and capillary injection solutions for upstream and midstream oil, gas and water customers. The Imperative brand was formed in 2019 through the merger of chemical businesses WadeCo Specialties, Impact Chemical Technologies and FloCap Injection Services. The group has over 550 employees in 32 locations serving customers across 12 US states.
Hempstead-based RSI Chemicals manufactures and supplies proprietary and custom solutions to the major oil & gas producing basins. RSI has more than 270 employees working at 20 locations.
Author: Elaine Burridge, Freelance Journalist
